Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kazuki Furuno
A Clinical Pharmacology Study of the Novel, Selective Urate Reabsorption Inhibitor Dotinurad in Outpatients
Clinical and Experimental Nephrology
Physiology
Nephrology
Related publications
Clinical Efficacy and Safety of Dotinurad, a Novel Selective Urate Reabsorption Inhibitor, in Japanese Hyperuricemic Patients With or Without Gout: Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group, Confirmatory Phase 2 Study
Clinical and Experimental Nephrology
Physiology
Nephrology
Pre-Clinical Pharmacology of AZD3965, a Selective Inhibitor of McT1: DLBCL, NHL and Burkitt’s Lymphoma Anti-Tumor Activity
Oncotarget
Oncology
A Selective FLT3 Inhibitor Shows Clinical Efficacy in AML
Cancer Discovery
Oncology
Functional Characterization of Urate Transport via a Novel Urate Efflux Transporter URATv1.
GOUT AND NUCLEIC ACID METABOLISM
Pharmacokinetics, Pharmacodynamics, and Tolerability of Verinurad, a Selective Uric Acid Reabsorption Inhibitor, in Healthy Japanese and Non-Asian Male Subjects
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
CGX1037 Is a Novel PKC Isoform Delta Selective Inhibitor in Platelets
Platelets
Medicine
Hematology
Pharmacology of a Phosphorus-Containing Novel Angiotensin Converting Enzyme Inhibitor, SQ29 852 in Anhesthetized Dogs.
Journal of Pharmacobio-Dynamics
First‐in‐human Phase I Study of E7090, a Novel Selective FGFR Inhibitor, in Patients With Advanced Solid Tumors
Cancer Science
Cancer Research
Medicine
Oncology
A First in Human Study of the Selective Cardiac Myosin Inhibitor, CK-3773274
Journal of Cardiac Failure
Cardiovascular Medicine
Cardiology
